RecruitingPhase 2 / Phase 3NCT06780670Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted TherapySponsor: Novartis PharmaceuticalsScottsdale, AZ · Los Angeles, CA · Palo Alto, CA · +32 more sites
RecruitingPhase 2 / Phase 3NCT04787744Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate CancerSponsor: VA Office of Research and DevelopmentLong Beach, CA · West Los Angeles, CA · Washington D.C., DC · +17 more sites
RecruitingPhase 2 / Phase 3NCT03495427PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test ScoresSponsor: H. Lee Moffitt Cancer Center and Research InstituteTampa, FL
Not yet recruitingPhase 2 / Phase 3NCT07574489Whole Versus Partial Gland Boost During Prostate SBRTSponsor: University of NebraskaOmaha, NE